DCAT Announces New Advisory Council Member
Robbinsville, NJ, November 1, 2016 – The Drug, Chemical & Associated Technology Association (DCAT) is pleased to announce that Oliver Technow, president of BioVectra, Inc., has been elected by the membership to serve on DCAT’s Advisory Council for a three-year term beginning November 1, 2016.
“We look forward to Mr. Technow’s contributions to the DCAT organization,” said Executive Director Margaret Timony. “He brings valuable industry experience and leadership skills that will help shape and support the organization’s programs, events and projects.”
More information on new DCAT Leadership can be found here.
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing. With over 400 corporate members, DCAT is headquartered in Robbinsville, New Jersey.